All figures: HFRI Fund Weighted Composite

HFRI MONTHLY INDICES

Source: HFR, HFRI Monthly Indices Flash Update, May 2026 (June 5, 2026). HFRI figures are flash update estimates subject to revision in subsequent HFRI updates. Past performance is not indicative of future results.

Beneath the composite, the month told a sharper story. Within a single strategy label — Equity Hedge — the Technology sub-index gained +10.63% while Healthcare lost −2.04%: a 12.67-point spread inside one strategy, in one month. Over the trailing twelve months the leadership flips entirely, with Healthcare up +45.70% against Technology's +35.83%. The strategy label on the door tells an allocator very little; the fund behind the door tells them everything.

RISK NO. 1 — CONCENTRATION

The S&P 500 Is No Longer a 500-Stock Bet

The ten largest constituents of the S&P 500 now account for roughly 41% of the index's weight — the highest level in decades, and more than double their share from the mid-2010s, when the top ten represented 18–23% of the index. The Magnificent Seven alone represent approximately 35–40% of total index capitalization. One widely cited measure puts the effective number of independent bets in the index at just 54 of its 503 constituents. An investor holding a standard cap-weighted S&P 500 fund is not holding the broad market; they are holding a concentrated mega-cap technology position with an index label on it.

Weight, however, understates the problem. The more important measure is risk contribution. Research published by a leading quantitative investment manager in January 2026, using S&P Global and LSEG data, found that the ten largest stocks now contribute more than 50% of the S&P 500's total volatility — and that the group's aggregate volatility runs roughly 1.5 times that of the index as a whole, with a market beta well above 1.0. That is a structural change from the early 2010s, when the largest names were a diverse set of lower-volatility blue chips — Apple alongside ExxonMobil and Johnson & Johnson — whose risk contribution sat below their index weight. Today's top ten are concentrated in correlated, technology-linked businesses, several of them among the most volatile large stocks in the market. The same research documents the knock-on effect: the distribution of betas inside the index has fractured, with nearly 20% of index weight in stocks carrying a beta below 0.5 and over 15% in stocks with a beta above 2.0 as of end-2025. The 'market portfolio' has become a barbell.

Honesty requires the counterpoint: this is not a simple replay of 1999. In the dot-com run-up, the weight of the largest stocks expanded while their share of earnings stayed flat — a pure multiple expansion. In the current episode, the earnings share of the largest companies has risen alongside their weight; a meaningful portion of the growth being priced has actually been delivered. But that cuts both ways. Because the concentration is partially earnings-supported, it is unlikely to unwind quickly; for the top-ten weight to revert to its pre-2020 average of roughly 21%, the other ~490 stocks would need to return more than 160% with the largest names flat. Concentration is not a temporary anomaly investors can wait out; it is the operating environment. And it is an expensive one: the top-ten stocks carry roughly 41% of index weight against roughly 32% of index earnings, the cap-weighted index trades at a nearly 30% premium to its equal-weighted counterpart, and Goldman Sachs estimates the S&P 500 will return approximately 3% annually over the coming decade.

Concentration is not only a risk to bear; it is an inefficiency to exploit — and that is where a hedge fund allocation may play a role in portfolio construction. The same concentration that degrades the index as a passive holding also mechanically handicaps long-only active managers: under a long-only constraint, a manager's largest possible underweight in any stock is that stock's index weight, and the share of S&P 500 names big enough to express a meaningful underweight (≥ 50 bps) has fallen from roughly 10% in 1997 to about 6% today. Concentration thus transfers alpha potential away from long-only mandates and toward managers who can short. Goldman Sachs data shows the typical hedge fund running roughly 72% of its long book in its top ten positions — concentrated where it has conviction, hedged where it does not. A long/short allocation is not merely a diversifier in a concentrated market; it may be better positioned to express these dynamics.

RISK NO. 2 — CORRELATION

The Hedge Has Become the Exposure

The case for the 40% bond sleeve was never primarily about yield; it was about correlation. From the mid-1980s through 2021, stocks and bonds reliably moved in opposite directions, and that negative correlation was the mechanical foundation of the 60/40 model. The relationship broke decisively in 2022, when the Bloomberg U.S. Aggregate fell 13.01% — its worst annual return on record — in the same year equities sold off sharply, handing a typical 60/40 portfolio a roughly 17.5% drawdown, its worst year since 1937.

The breakdown was not a one-year accident. As of June 9, 2026, the 60-day rolling correlation between the iShares Core U.S. Aggregate Bond ETF (AGG) and the S&P 500 ETF (SPY) stands at +0.70 — within two points of the highest reading (+0.72) in the entire data series going back to December 2003, a span that covers the global financial crisis, the 2013 taper tantrum, the 2020 pandemic shock, and the 2022 repricing. For most of those two decades the same measure was negative, frequently below −0.50. The IMF and multiple institutional research teams attribute the regime change to a structural shift: the reliably negative correlation of 1985–2021 was a product of falling inflation and falling rates. In a regime of persistent inflation risk, heavy sovereign issuance, and structurally higher neutral rates, stocks and bonds can remain positively correlated for extended periods. When both sleeves move together, the 40% allocation is not a diversifier — it is additional exposure to the same macro factor, dressed in safer clothing.

RISK NO. 3 — DURATION

More Rate Sensitivity, Exactly When It Hurts

The third risk compounds the second. The duration of the Bloomberg U.S. Aggregate Bond Index — the standard proxy for the '40' — stood at 5.79 years as of March 2026, against a long-run average of 4.98 years and roughly 4.5 years in 2006. The benchmark bond sleeve therefore carries approximately 30% more interest-rate sensitivity than it did twenty years ago, and remains well above its historical norm even after declining from its 2021–2022 peak. As a first-order approximation, a portfolio with 5.8 years of duration loses roughly 5.8% of its value for every one-percentage-point parallel rise in rates, before income offsets.

Each risk in isolation is manageable. The combination is the problem. Elevated bond duration makes the 40% sleeve more sensitive to rates and inflation — and that same variable reaches the equity sleeve through an identical channel. A stock is worth the present value of its future cash flows, so when most of that value sits in distant, terminal-year cash flows, the equity behaves like a long-duration asset whose price falls as discount rates rise. The concentrated mega-cap growth names that now dominate the index (Risk No. 1) are precisely the longest-duration equities, which is a central reason stocks and bonds have begun to fall together: the index's tilt toward them has effectively lengthened the equity sleeve's own rate sensitivity. Duration risk, in other words, is not confined to the 40%; it runs through both sleeves. With the 10-year Treasury at 4.54%, AGG roughly −0.5% year-to-date through late May, and a Federal Reserve positioned for at most one further cut this year, a 60/40 investor today is effectively long one macro factor — rates — twice over, with extra duration attached.

04 — Second Half 2026

The Hedge Fund Industry Positions for the Second Half of 2026

The conditions behind these results are structural, not episodic. The late-2010s era of hedge fund industry underperformance was built on compressed dispersion — zero rates, synchronized growth, passive beta capturing everything. 2022–2026 has inverted each of those conditions: rates are positive, dispersion within and across markets has widened, geopolitics generates repeated regime-change events, and AI is producing winner-take-most dynamics that skilled managers can trade on both sides of the book.

Cambridge Associates describes the environment — elevated dispersion, low correlations, policy uncertainty — as structurally favorable for long/short managers; Wellington reaches the same conclusion for hedge fund allocations broadly. Three specific second-half catalysts stand out: an expected record IPO calendar (directly supportive of event-driven and activist strategies), the policy clarity following the Warsh Fed confirmation, and a cleaner macro environment as April's oil distortion unwinds.

None of that depends on equities going up — only on markets continuing to differentiate. But differentiation cuts both ways: the same forces that reward skilled managers widen the gap between the best and worst funds, which makes capturing this environment less a question of access to hedge funds than of selecting the right ones.